Abhijit Kshirsagar
Overview
Explore the profile of Abhijit Kshirsagar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wyatt L, Xi Y, Kshirsagar A, Di Q, Ward-Caviness C, Wade T, et al.
BMJ Open
. 2020 Dec;
10(12):e041177.
PMID: 33323443
Objectives: To examine the effect of short-term exposure to ambient fine particulate matter (PM) on all-cause, cardiovascular and respiratory-related hospital admissions and readmissions among patients receiving outpatient haemodialysis. Design: Retrospective...
2.
Babayev R, Whaley-Connell A, Kshirsagar A, Klemmer P, Navaneethan S, Chen S, et al.
Am J Kidney Dis
. 2012 Dec;
61(3):404-12.
PMID: 23260275
Background: A recent cross-sectional analysis of Kidney Early Evaluation Program (KEEP) participants suggested that obesity is a heterogeneous disease state in African Americans and whites with chronic kidney disease (CKD)....
3.
Shoham D, Durazo-Arvizu R, Kramer H, Luke A, Vupputuri S, Kshirsagar A, et al.
PLoS One
. 2008 Oct;
3(10):e3431.
PMID: 18927611
Background: End-stage renal disease rates rose following widespread introduction of high fructose corn syrup in the American diet, supporting speculation that fructose harms the kidney. Sugar-sweetened soda is a primary...
4.
Joy M, Kshirsagar A, Candiani C, Brooks T, Hudson J
Ann Pharmacother
. 2006 Feb;
40(2):234-40.
PMID: 16449551
Objective: To review the pharmacology, pharmacokinetics, clinical efficacy, and safety profile of lanthanum carbonate, a phosphate binder for chronic kidney disease (CKD). Data Sources: Information was selected from PubMed (1965-October...
5.
Krause M, Massing M, Kshirsagar A, Rosamond W, Simpson Jr R
Ren Fail
. 2004 Dec;
26(6):715-25.
PMID: 15600265
Background: Individuals with chronic kidney disease have a high mortality rate after acute myocardial infarction. It is not known how frequently these individuals are prescribed combination cardioprotective therapy and if...
6.
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism
Franceschini N, Joy M, Kshirsagar A
Expert Opin Investig Drugs
. 2003 Jul;
12(8):1413-21.
PMID: 12882626
Cinacalcet HCl (AMG 073) is an investigational oral calcimimetic drug currently being evaluated for the treatment of primary and secondary hyperparathyroidism (HPT). Calcimimetics bind to the calcium-sensing receptors of the...
7.
Paparello J, Kshirsagar A, Batlle D
Semin Nephrol
. 2002 Nov;
22(6):494-506.
PMID: 12430094
The mortality rate among dialysis patients is high. Although guidelines have been in place to improve outcomes in dialysis patients, new emphasis is being placed on better management of patients...